Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian

NCT03412526 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER_GOV

Sponsor class

Conditions

Metastatic Ovarian Cancer

Interventions

DRUG: Fludarabine
RADIATION: Radiation
BIOLOGICAL: TIL administration
DRUG: IL-2

Sponsor

Sheba Medical Center